Peter Brown

Stock price provided by Lang & Schwarz

Showing transactions by Peter Brown in Teva Pharmaceutical Industries Limited.

Quarter	Type	Shares before	Shares after	Change	Price range
2025-Q1	Sell	7M	5.3M	-1.7M	€13.50–€21.50
2024-Q4	Sell	8.1M	7M	-1.1M	€15.50–€22.00
2024-Q3	Sell	8.7M	8.1M	-616K	€14.70–€17.10
2024-Q2	Buy	7.7M	8.7M	+1M	€12.05–€16.25
2024-Q1	Buy	5.4M	7.7M	+2.3M	€9.78–€13.30
2023-Q4	Buy	4M	5.4M	+1.4M	€7.66–€9.70
2023-Q3	Sell	6.5M	4M	-2.5M	€6.84–€9.98
2023-Q2	Buy	6.5M	6.5M	+5.4K	€6.62–€8.66
2023-Q1	Buy	4.6M	6.5M	+1.9M	€7.80–€10.35
2022-Q4	Buy	4.3M	4.6M	+251K	€7.88–€9.18
2022-Q3	Buy	4.1M	4.3M	+195K	€6.79–€11.00
2022-Q2	Buy	2.6M	4.1M	+1.6M	€6.99–€9.64
2022-Q1	Buy	965K	2.6M	+1.6M	€6.74–€8.40
2021-Q4	Buy	36K	965K	+929K	€6.93–€8.82
2021-Q3	Sell	946K	36K	-911K	€7.07–€8.59
2021-Q2	Sell	1.1M	946K	-193K	€8.29–€9.73
2020-Q3	Sell	4.1M	1.1M	-3M	€7.38–€10.88
2020-Q2	Buy	3.2M	4.1M	+892K	€7.49–€11.80
2020-Q1	Buy	2.2M	3.2M	+967K	€6.23–€12.42
2019-Q4	Sell	6.9M	2.2M	-4.7M	€5.93–€9.68
2019-Q3	Sell	9.8M	6.9M	-2.8M	€5.50–€8.78
2019-Q2	Buy	2.6M	9.8M	+7.2M	€7.22–€14.01
2019-Q1	Sell	6.9M	2.6M	-4.3M	€13.81–€17.60
2018-Q4	Buy	3.5M	6.9M	+3.5M	€13.19–€21.08
2018-Q3	Buy	901K	3.5M	+2.6M	€18.20–€22.03
2018-Q1	Sell	4.8M	901K	-3.9M	€13.51–€18.60
2017-Q1	Buy	2.2M	4.8M	+2.7M	€29.96–€36.06
2016-Q4	Buy	1.9M	2.2M	+218K
2016-Q3	Buy	1.4M	1.9M	+560K
2016-Q2	Buy	1.2M	1.4M	+197K
2016-Q1	Buy	533K	1.2M	+659K
2015-Q4	Sell	2.9M	533K	-2.3M
2015-Q3	Buy	2.1M	2.9M	+803K
2015-Q2	Buy	1.3M	2.1M	+737K
2015-Q1	Buy	965K	1.3M	+374K
2014-Q4	Buy	265K	965K	+700K
2014-Q3	Sell	505K	265K	-240K
2014-Q2	Buy	298K	505K	+206K

Transactions may be incomplete if the investor has purchased shares of the company before they reached the threshold for reporting set in the Securites Exchange Act or other applicable laws.

← Back to all investors